Lisuride
| Lisuride | |
|---|---|
| Lisuride.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Lisuride is a dopamine receptor agonist of the ergoline class, primarily used in the treatment of Parkinson's disease and migraine prophylaxis. It is chemically related to LSD but does not possess the same hallucinogenic properties.
Pharmacology[edit]
Lisuride acts as an agonist at dopamine D2 receptors, which are involved in the regulation of movement and coordination. This makes it effective in managing symptoms of Parkinson's disease, a condition characterized by dopamine deficiency in the brain.
Mechanism of Action[edit]
Lisuride binds to dopamine receptors, mimicking the action of dopamine, which is deficient in patients with Parkinson's disease. This helps to alleviate symptoms such as tremors, stiffness, and bradykinesia.
Medical Uses[edit]
Lisuride is used in the management of several conditions:
- Parkinson's disease: It helps in reducing motor symptoms by compensating for the lack of dopamine.
- Migraine: Lisuride is used prophylactically to reduce the frequency and severity of migraine attacks.
Side Effects[edit]
Common side effects of lisuride include nausea, dizziness, and fatigue. In some cases, it may cause more serious effects such as hallucinations or hypotension.
History[edit]
Lisuride was developed in the 1960s and has been used in clinical practice since the 1970s. It was initially investigated for its potential in treating schizophrenia but was found to be more effective in managing Parkinson's disease and migraines.
Chemical Structure[edit]
Lisuride is an ergoline derivative, sharing structural similarities with other compounds in this class, such as bromocriptine and cabergoline.
